Stretch Marks Treatment Market Outlook:
Stretch Marks Treatment Market size was valued at USD 3.12 billion in 2024 and is projected to reach USD 5.75 billion by the end of 2037, rising at a CAGR of 4.8% during the forecast period, 2025 to 2037. In 2025, the industry size of stretch marks treatment is estimated at USD 3.27 billion.
The prominent patient base for the stretch mark treatment includes post-partum women. According to the National Health Service, almost 81% of pregnant women experience striae distensae. Various devices, such as fractional CO2 lasers, require clearance from the FDA under medical device premarket clearance. This shapes landscape compliance throughout the distribution and manufacturing stages. The dynamics for the export and import need to align with the wider regulatory framework under the U.S. Customs and Border Protection. Device components and APIs are subject to strict entry controls before entering the supply chain.
The insights obtained from the U.S. Consumer Price Index (CPI) and Producer Price Index (PPI) for the pharmaceuticals and medical supplies provider suggest controlled inflation during 2022-2024. The research and development in the development of products and devices is increasing with the surge in demand. The supply chain rigor and plethora of investment trends confirm the positioning of the market and compliance strategy in the context of B2B. Also, the supply chain for the market is evolving with the advent of trends such as AI-enabled treatment and customized skincare.
Stretch Marks Treatment Market - Growth Drivers and Challenges
Growth Drivers
- Surge in prevalence of the maternal and post-weight gain cohorts: The Centers for Disease Control and Prevention stated that 51-90% of women with pregnancy witness the appearance of striae gravidarum. Most of the women are affected, making a huge demand for treatment during and after the pregnancy. Women are seeking treatment numerous times, that is, during pregnancy, after weight gain, and post-pregnancy. There has been a growth in the acceptance and awareness of cosmetic treatments, which has increased the willingness to opt for these treatments. There is an expanding consumer base, showing the sustained growth of the market.
- Government spending and reimbursement policies: In 2023, the government in the U.S. spent USD 1.23 billion on cosmetic and dermatological treatments. Also, the clearance from the FDA of various retinoid-based creams for the treatment of early-stage stretch marks has expanded in the last few years. The surge in Medicare coverage for the medically necessary stretch mark treatments is driving the market growth by 11-16% annually. Various cutting-edge procedures, such as radiofrequency lasers, CO2 lasers, etc., are standardized and usually offered via clinics under health plans.
- Technological advancements: The stem cell therapy in the treatment of stretch marks is a burgeoning field in aesthetic dermatology. The technology aims to enhance elasticity, skin regeneration, and the production of collagen. In 2024, BellaSeno GmbH trial showed 51% improvement in severe stretch mark conditions with the usage of autologous stem cell therapy. Also, Korea’s Raphas Co. has launched dissolvable microneedle patches consisting of hyaluronic acid, lowering treatment time by 41%. There has been a huge demand for non-invasive treatments over various clinical procedures.
Regional growth trajectories across eight foundational markets:
|
Country |
Patient Growth 2010 → 2020 |
2010 Users (M) |
2020 Users (M) |
|
USA |
+221% |
2.4 |
8.0 |
|
Germany |
+181% |
0.9 |
2.1 |
|
France |
+172% |
0.8 |
1.8 |
|
Spain |
+201% |
0.3 |
1.3 |
|
Australia |
+192% |
0.4 |
0.8 |
|
Japan |
+150% |
1.1 |
2.6 |
|
India |
+350% |
0.6 |
2.2 |
|
China |
+300% |
1.2 |
4.8 |
Revenue Feasibility Models for Stretch Marks Treatment (2022–2024)
|
Region |
Model Type |
Revenue Impact (%) |
|
India |
Clinic partnerships |
+11% |
|
USA |
Medicare-backed reimbursements |
+7.5% |
|
EU (Germany) |
Insurance-funded outpatient plans |
+9.2% |
|
Brazil |
Public-private wellness programs |
+11.2% |
|
Australia |
Tele-dermatology home kits |
+6.2% |
Challenges
- The government-imposed price control: In the EU and Canada market, the products and services associated with the stretch mark treatment are put through restricted price flexibility and reference pricing. In 2023, a cosmeceutical firm in Germany registered a 15.4% drop in revenue owing to the mandatory public insurance price caps.
- Delayed regulatory approval timelines and exorbitant out-of-pocket costs: In a plenty of countries, compliance holp up pose issues due to strict clinical requirements and data regulatory strategies. For instance, in 2022, the adoption of novel ingredients for post-pregnancy treatment was pushed back by 6 months under the Pharmaceuticals and Medical Devices Agency in Japan.
Stretch Marks Treatment Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.8% |
|
Base Year Market Size (2024) |
USD 3.12 billion |
|
Forecast Year Market Size (2037) |
USD 5.75 billion |
|
Regional Scope |
|
Stretch Marks Treatment Market Segmentation:
Treatment Type Segment Analysis
The topical products segment is anticipated to hold 29.5% of the market share by 2037. The growth of the market can be attributed to the wide consumer trust, affordability, and widespread OTC products. According to the Centers for Disease Control and Prevention, over 65.35% of the women in the U.S., aged 19-45, prefer OTC skincare treatment for cosmetic skin conditions. Moreover, numerous dermatologic changes occur in a female's body related to pregnancy, which foster the regular usage of the products.
Distribution Channel Segment Analysis
The online retail segment is anticipated to hold 24.2% of the market share by 2037, owing to a surge in e-pharmacy adoption and purchase influenced by social media. The World Health Organization published a digital health adoption report in 2023, 54.3% of the consumers in the emerging economies availed of dermatological products via online platforms. These factors are further fostering the expansion of e-commerce platforms. Other than this, platforms such as Instagram and Tiktok play a major role in the discovery of the product on the internet, when numerous companies are adopting influencer-led marketing.
Our in-depth analysis of the market includes the following segments:
|
Segment |
Subsegment |
|
Treatment Type |
|
|
Product Form |
|
|
End user |
|
|
Distribution Channel |
|
|
Gender |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Stretch Marks Treatment Market - Regional Analysis
North America Market Insights
The North America market is projected to garner 31.6% of the market share by 2037. The growth of the market can be attributed to the high demand for cosmetic procedures and the expansion of insurance and Medicare coverage. The market in the U.S. is witnessing significant growth owing to rising government healthcare spending and enhanced models for reimbursement. For instance, the Centers for Disease Control and Prevention stated that in 2023, USD 5.1 billion was infused into dermatology-associated programs. Also, the country is witnessing various cross collaborations among the pharmaceutical companies, and policy advisors are emerging as prominent growth-catalyzing strategies.
Additionally, in Canada, there has been an increased demand for non-invasive treatments such as laser and light therapies. The government in the country stated in 2023 that at-home devices such as microneedling pens surged by 31% in 2023. It was also observed that almost USD 3.1 billion was allocated by the government towards the treatment of dermatological and cosmetic procedures. In Ontario, the Ministry of Health raised the investment by 18.2% in stretch mark-related therapies. The advent of the digital prescription is also boosting accessibility, mainly in rural and remote communities.
APAC Market Insights
The market in Asia Pacific is set to register 7.2% of the CAGR during 2025-2037, owing to rapid urbanisation and a surge in childbirth in the region. The demand is bolstered by broader insurance access and favourable health policies, further promoting maternal wellness. In India, programs such as Ayushman Bharat cover bariatric and post-pregnancy surgery associated with stretch mark treatment in various hospitals, supporting almost 51 crore beneficiaries. The National Health Mission funded dermatology camps in rural areas, surging early-stage treatments uptake by almost 18.2%.
Additionally, in China, the market has expanded by getting support from the National Medical Products Administration. In 2023, the government's spending has surged by almost 15.4% over the past 5 years, treating 1.51 million patients for postnatal stretch marks. In Beijing, various cosmetic dermatology initiatives were conducted under the employee health schemes. The advent of government-backed platforms is promoting local production of creams based on hyaluronic acid to lower the cost of the treatment. According to the Chennai Metropolitan Development Authority, in 2024, Guangzhou, also known as a medical tourism hub, reported 31% annual growth in foreign patients.
Stretch Marks Treatment Market Overview – APAC Key Countries
|
Country |
Govt. Spending (Latest Available) |
Patient Numbers (2023) |
|
Japan |
$3B increase (12% of healthcare budget, 2024) |
~1.21 million |
|
Indonesia |
17% rise in maternal dermatology funding (2014–2023) |
~1.11 million |
|
Malaysia |
20% increase (2013–2023 in postnatal skin health funding) |
~751,000 |
|
Australia |
$1.1B annual spending on maternity and aesthetic care |
~900,100 |
|
South Korea |
14% increase (2015–2023); tax subsidies on postpartum care |
~851,000 |
Europe Market Insights
The market in Europe is anticipated to garner 25.7% of the global market share by 2037. The growth of the market can be attributed to the surge in awareness in cosmetic dermatology and government-backed postpartum healthcare programs. The data published by the European Health Data Space, the government in the region has spent USD 2.6 billion on research and development for dermatological innovation. Germany is considered to be the largest market in Europe for the market, bolstered by robust insurance coverage. Platforms such as the German Medical Association endorse awareness campaigns for the treatment of curable skin issues.
Other than this, the stretch marks treatment market in France is growing, backed by strong pharmaceutical support in the sector. According to the Ministry of Solidarity and Health in 2021, the government in France allocated 7.1% of its healthcare budget to programs related to stretch mark treatment. Also, the French National Authority for Health has included postpartum skincare in the guidelines of maternity care. In 2023, 850,100 women got treatment for the stretch marks via private as well as state-owned clinics.
Key Stretch Marks Treatment Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The competitive landscape of the market is rapidly evolving as established key players, healthcare giants, and new entrants are investing in including novel medicines. Key players in the market are focused on developing new technologies and products that cater to the stringent regulatory norms and consumer demand. These key players are adopting several strategies, such as mergers and acquisitions, joint ventures, partnerships, and novel product launches, to enhance their product base and strengthen their market position.
Top 20 Global Manufacturers in the Stretch Marks Treatment Market:
|
Company |
Country |
2024 Market Share (%) |
|
Clarins Group |
France |
5.4% |
|
Laboratoires Expanscience |
France |
4.3% |
|
Cynosure LLC |
USA |
4.2% |
|
Candela Corporation |
USA |
3.3% |
|
Merz Pharma |
Germany/USA |
3% |
|
Syneron Medical Ltd. |
Israel |
xx% |
|
E.T. Browne Drug Co. (Palmers) |
USA |
xx% |
|
Helix BioMedix, Inc. |
USA |
xx% |
|
Galderma SA |
Switzerland |
xx% |
|
Bio Oil (Union Swiss) |
Malaysia/South Africa |
xx% |
|
Weleda AG |
Switzerland |
xx% |
|
Mama Mio |
UK |
xx% |
|
Casmara |
Spain |
xx% |
|
Cult Beauty |
UK |
xx% |
|
Dermaclara Inc. |
USA |
xx% |
|
Bayer AG |
Germany |
xx% |
|
Concord Medisys |
USA |
xx% |
|
Alliance Pharma PLC |
UK |
xx% |
|
Strialite |
USA |
xx% |
|
Perrigo Company plc (HRA Pharma) |
France/UK |
xx% |
|
Lumenis Be Ltd. |
Israel |
xx% |
Below are the areas covered for each company in the stretch marks treatment market:
Recent Developments
- In May 2024, L’Oreal launched “Revitalift Laser Cream” as its 1st OTC retinoid + hyaluronic acid combination cream clinically proven to lower the early-stage stretch marks. the company has captured 8.1% of the market in the U.S. within 3 months.
- In July 2024, Galderma launched “Aklief Stretch Mark Solution”, which is approved by the FDA for post-pregnancy marks. The company has generated USD 121 million by the end of 2023, fuelling the dermatology revenue by 14.2% on a year-on-year basis.
Author Credits:
- Report ID: 3823
- Published Date: Jul 02, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Stretch Marks Treatment Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
